| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 258.037 | 195.527 | 83.885 | 73.556 | 78.499 | 346.710 | 207.834 | 943.533 | 148.361 | 86.667 |
| Total Income - EUR | 275.067 | 195.527 | 112.088 | 73.556 | 78.714 | 805.795 | 608.139 | 1.082.906 | 148.361 | 86.667 |
| Total Expenses - EUR | 264.220 | 180.619 | 55.626 | 32.179 | 41.614 | 645.413 | 524.690 | 695.835 | 101.729 | 70.831 |
| Gross Profit/Loss - EUR | 10.847 | 14.908 | 56.462 | 41.377 | 37.100 | 160.382 | 83.449 | 387.071 | 46.632 | 15.836 |
| Net Profit/Loss - EUR | 9.075 | 12.364 | 55.012 | 40.646 | 36.312 | 156.589 | 81.620 | 378.203 | 45.297 | 12.091 |
| Employees | 22 | 7 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 |
Check the financial reports for the company - Luctonifrim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 305.658 | 280.650 | 257.108 | 266.875 | 259.296 | 210.412 | 182.884 | 151.047 | 92.715 | 70.381 |
| Current Assets | 81.207 | 91.915 | 31.878 | 176.112 | 440.011 | 378.716 | 823.785 | 804.731 | 634.655 | 672.195 |
| Inventories | 47.656 | 0 | 0 | 110.708 | 381.318 | 295.053 | 600.890 | 249.209 | 243.344 | 209.529 |
| Receivables | 23.722 | 8.100 | 31.642 | 44.485 | 55.112 | 79.519 | 217.949 | 419.489 | 104.768 | 436.444 |
| Cash | 9.829 | 83.815 | 236 | 20.918 | 3.582 | 4.144 | 4.945 | 136.034 | 305.184 | 44.758 |
| Shareholders Funds | 42.193 | 54.126 | 108.222 | 146.883 | 180.350 | 333.520 | 407.744 | 787.212 | 532.197 | 529.545 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 344.672 | 318.439 | 180.763 | 296.104 | 518.958 | 255.607 | 598.925 | 168.566 | 195.173 | 213.031 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Luctonifrim S.r.l.